Bratei et al., 2023 in their series of studies were able to differentiate 28 patients confirmed with gastric cancer and 31 patients confirmed with colorectal cancer based on Maspin, MLH1, PMS2, and K-Ras biomarkers in saliva [59,98,99]. Here, PMS2 is linked to gastric cancer.